News

Senior Development Manager – BioCurate

Exciting start-up opportunity Transform the way new medicines are developed Competitive salary package Inner city location The Company BioCurate is a bold new $80 million venture that has been formed to specifically address the well-known ‘valley of death’…

The US drug pricing debate: Managing risks to results

EY report on drug pricing The unsustainable trajectory of the health care spending in the US is generating much dialog and consternation across a variety of stakeholders including governments, industry, media academic think-tanks and the general public. Prescription…

New Director of Bio 21 announced

Professor Michael Parker has been appointed as the new Director of the University of Melbourne’s Bio 21 Molecular Science and Biotechnology Institute. One of Australia’s leading protein structural biologists, Prof Parker will take up the role as part…

Atomic map gives malaria drug new lease on life

Researchers have for the first time mapped how one of the longest-serving malaria drugs works, opening the possibility of altering its structure to make it more effective and combat increasing malaria drug resistance. The study produced a precise…

Catalyst for efficient drug and chemical production

A team of CSIRO scientists have made a breakthrough that could result in faster and cheaper production for the pharmaceutical, food and bulk chemistry industries. The team have developed a more efficient and simpler process that – when…

Medical Countermeasures EOI – Documentation release

The Defence Materials Technology Centre (DMTC) is a not for profit collaborative venture that brings together defence industry, universities and government research agencies to develop technologies that will enhance Australia’s defence and national security capability. The Medical Countermeasures…

24th March – China Market Entry & Investment

Opportunities for companies in Cleantech, Medtech & Agtech Invest Shenzhen invites you to attend a free Seminar on Friday 24 March 2017 Time: 1:30pm until 4:30pm Where: In the Yarra Room at the Melbourne Town Hall, 90-120 Swanston…

Fellowship Brings Leading Cancer Researcher To Victoria

One of the world’s best cancer researchers working to accelerate future treatments through DNA repair has received support from the Andrews Labor Government and veski to undertake research here in Victoria. Minister for Small Business, Innovation and Trade…

IP and BD Manager – Part-time 3 days a week, 12-month fixed term contract

INTELLECTUAL PROPERTY AND BUSINESS DEVELOPMENT MANAGER Initially part-time (3 days per week), 12 month fixed term contract Challenging role for motivated self-starter Experienced IP and BD manager role Work from home anywhere in Australia About the business and…

Bone, cartilage and tissue; we’ve cracked the trifecta (and it’s made of titanium and plastic)

We’ve been quietly working away in Melbourne on something big. The big trifecta of a bone, cartilage and tissue implant. The first of its kind. More specifically, a 3D printed titanium and polymer sternum to suit individual patients.  …

Nominations are now open for the 2017 Australian Museum Eureka Prizes – Australia’s premier national science awards

Entries close 7pm AEST Friday 5th May Australian Museum Eureka Prizes Presented annually, the Australian Museum Eureka Prizes reward excellence in the fields of research & innovation, leadership, science engagement and school science. For more on the Australian…

Medical Developments International Limited: Penthrox: Second order for UK and Ireland

Medical Developments International Limited (ASX: MVP) advises it received a large second order for Penthrox from its partner Galen Pharmaceuticals Ltd (Galen) for the United Kingdom (UK) and Republic of Ireland (Ireland). MVP CEO, Mr. John Sharman, said:…

Home

News & opinion

Member Directory

Events